| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5824805 | Clinical Therapeutics | 2015 | 17 Pages |
Abstract
We determined that the results were highly sensitive to the rate ratio. However, the addition of PMRT for patients with pN1-3 in China has a reasonable chance to be cost-effective and may be judged as an efficient deployment of limited health resource, and the risk and uncertainty of PMRT are relatively greater for patients with pN4+.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Xiaomin PhD, Liubao BS, Jinan PhD, Gannong MS, Yuanjian PhD,